Jane Street
VYNT

Jane Street’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Jane Street’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-104
Closed -$235K – 3259
2014
Q1 		$235K Buy
+104
New +$266K ﹤0.01% 2223
2013
Q4 		– Sell
-184
Closed -$558K – 3018
2013
Q3 		$558K Buy
+184
New +$315K 0.01% 1618

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $223M AUM 17.15% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Jane Street's VYNT Position: Q2 2014 in Review

Jane Street sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2014, closing a stake of 104 shares — an estimated $235K sold.

Jane Street first reported a position in VYNT in Q3 2013 and held it in 2 quarters. The position peaked at $558K in Q3 2013. 34 funds tracked by Wall St. Rank hold VYNT as of Q2 2014.

  • Jane Street reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Jane Street sold 104 Vyant Bio, Inc. Common Stock shares in Q2 2014, an estimated $235K.
  • Jane Street first reported a position in Vyant Bio, Inc. Common Stock in Q3 2013 and held it in 2 quarters.
  • Jane Street's Vyant Bio, Inc. Common Stock position peaked at $558K in Q3 2013.
  • 34 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2014.

Based on Jane Street's 13F filing for Q2 2014, filed 14 Aug 2014.